Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium species are protozoan parasites responsible for malaria in humans. The blood stage of these parasites is clinically significant, as it is responsible for the symptoms and pathology of malaria. The most important human-infecting species include Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. This stage is targeted by most antimalarial drugs.
Inhibition of parasite enzymes, disruption of parasite metabolism, interference with hemoglobin digestion, disruption of mitochondrial function, prevention of gametocyte development
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium Species (Blood Stage).